Physician profile
Jack A Taylor
NPI 1467477505
$1,773.67
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,206 · 2020: $545 · 2021: $22.67.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $255.57 | 2019 | |
| Pfizer INC. | $155.72 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.66 | 2019-2020 | |
| Amgen INC. | $146.07 | 2019-2020 | |
| Amarin Pharma, INC. | $134.65 | 2019-2020 | |
| Novo Nordisk INC | $129.39 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $118.67 | 2019 | |
| Glaxosmithkline, LLC. | $79.25 | 2019-2020 | |
| Dynavax Technologies Corporation | $69.97 | 2019 | |
| Gilead Sciences, INC. | $67.47 | 2019 | |
| Sanofi-Aventis U.S. LLC | $66.01 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $51.62 | 2019-2020 | |
| Boston Scientific Corporation | $49.32 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.09 | 2020 | |
| Sanofi Pasteur INC. | $30.06 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $28.23 | 2020 | |
| Upsher-Smith Laboratories LLC | $27.68 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $26.83 | 2019-2020 | |
| Shire North American Group INC | $24.76 | 2019 | |
| Abbvie INC. | $22.67 | 2021 | |
| Genentech USA, INC. | $16.75 | 2020 | |
| Astellas Pharma US INC | $14.97 | 2019 | |
| Assertio Therapeutics, INC. | $13.61 | 2019 | |
| Seqirus USA INC | $12.66 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.60 | 2020 | |
| Circassia INC. | $11.96 | 2019 | |
| Lilly USA, LLC | $11.27 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.